Our latest news, articles, and research.
January 29, 2020
STS 2020: Intraoperative Molecular Imaging Technology Helps Surgeons to Detect NSCLC
January 27, 2020
Intraoperative Molecular Imaging of Non-Small Cell Lung Cancer Improves Outcomes for 26 Percent of Patients in Multi-Institutional Phase 2 Clinical Trial
October 15, 2019
Positive Phase 2 Study Results Published for On Target's Intraoperative Cancer Imaging Agent.
August 19, 2019
On Target Completes OTL38 Phase 2 Clinical Trial in Lung Cancer
August 12, 2019
On Target Laboratories Appoints Chief Executive Officer
October 15, 2018
On Target Laboratories Announces Publication Supporting Use of OTL78 to Highlight Prostate Cancer Lesions
November 1, 2017
On Target Laboratories secures $40 million financing led by Johnson & Johnson Innovation-JJDC, Inc. (JJDC)
August 17, 2017
Founder, Dr. Phil Low, discusses the future of fluorescent guided surgery with Moira Gunn on NPR's "Tech Nation"
January 4, 2017
On Target Laboratories files more patents for promising cancer treatment technology
May 4, 2015
Funding milestone reached for "light up" cancer cell research in both lung and ovarian cancer
Alchemy + Aim